Westover, Angela J.
Humes, H. David
Pino, Christopher J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (2R44 TR001324)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1R43 HL164239-01)
Article History
Received: 7 July 2023
Accepted: 24 May 2024
First Online: 3 June 2024
Competing interests
: AJW, HDH and CJP are shareholders of SeaStar Medical, a publicly traded company commercializing SCD technology.